Navigating the Evolving Treatment Landscape in HER2-mutated NSCLC - Episode 3

Role of ADCs in HER2-Mutated NSCLC

, , , ,

The panel discusses the role of antibody-drug conjugates (ADCs) and the treatment of patients with HER2-mutated non–small cell lung cancer.